BMS expands precision oncology portfolio with Turning Point acquisition
The pharmaceutical company has completed acquisition of Turning Point Therapeutics, a company specializing in precision medicine solutions for cancer patients.
The pharmaceutical company has completed acquisition of Turning Point Therapeutics, a company specializing in precision medicine solutions for cancer patients.
The pharma firm will leverage the ClinTech leader's Life Science Analytics Cloud to bolster development capabilities and accelerate pipeline progress.